- Home
- CVR vs SNSE Comparison
CVR vs SNSE Comparison
Compare CVR & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVR
- SNSE
- Stock Information
- Founded
- CVR 1920
- SNSE 2005
- Country
- CVR United States
- SNSE United States
- Employees
- CVR N/A
- SNSE N/A
- Industry
- CVR Industrial Machinery/Components
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- CVR Industrials
- SNSE Health Care
- Exchange
- CVR Nasdaq
- SNSE Nasdaq
- Market Cap
- CVR 11.1M
- SNSE 10.8M
- IPO Year
- CVR N/A
- SNSE 2021
- Fundamental
- Price
- CVR $12.13
- SNSE $7.49
- Analyst Decision
- CVR
- SNSE Strong Buy
- Analyst Count
- CVR 0
- SNSE 4
- Target Price
- CVR N/A
- SNSE $72.50
- AVG Volume (30 Days)
- CVR 1.8K
- SNSE 31.3K
- Earning Date
- CVR 08-08-2025
- SNSE 08-05-2025
- Dividend Yield
- CVR 0.99%
- SNSE N/A
- EPS Growth
- CVR N/A
- SNSE N/A
- EPS
- CVR N/A
- SNSE N/A
- Revenue
- CVR $25,617,681.00
- SNSE N/A
- Revenue This Year
- CVR N/A
- SNSE N/A
- Revenue Next Year
- CVR N/A
- SNSE N/A
- P/E Ratio
- CVR N/A
- SNSE N/A
- Revenue Growth
- CVR N/A
- SNSE N/A
- 52 Week Low
- CVR $8.15
- SNSE $5.00
- 52 Week High
- CVR $22.27
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- CVR 46.78
- SNSE 47.35
- Support Level
- CVR $11.44
- SNSE $6.33
- Resistance Level
- CVR $13.25
- SNSE $10.99
- Average True Range (ATR)
- CVR 0.28
- SNSE 0.98
- MACD
- CVR 0.04
- SNSE -0.03
- Stochastic Oscillator
- CVR 37.85
- SNSE 24.97
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).